UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of COVID-19 on Madrid hospital system

Enfermedades infecciosas y microbiologia clinica (English ed.), 2021-05, Vol.39 (5), p.256-257

2021

Volltextzugriff (PDF)

Which trial do we need? Management of elderly, fragile, fully vaccinated patients hospitalized for SARS-CoV-2 infection

Clinical microbiology and infection, 2023-04, Vol.29 (4), p.419-421

2023

Volltextzugriff (PDF)

Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial

The Lancet infectious diseases, 2014-07, Vol.14 (7), p.572-580

2014

Volltextzugriff (PDF)

Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy : A Cohort Study

Annals of internal medicine, 2020-10, Vol.173 (7), p.536-541

2020

Volltextzugriff (PDF)

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2020-09, Vol.324 (11), p.1048

2020

Volltextzugriff (PDF)

Clinical Management of Ebola Virus Disease in the United States and Europe

The New England journal of medicine, 2016-02, Vol.374 (7), p.636-646

2016

Volltextzugriff (PDF)

Probable sexual transmission of Zika virus from a vasectomised man

The Lancet infectious diseases, 2016-10, Vol.16 (10), p.1107-1107

2016

Volltextzugriff (PDF)

Broadly Neutralizing Antibodies for Human Immunodeficiency Virus Treatment: Broad in Theory, Narrow in Reality

Clinical infectious diseases, 2023-03, Vol.76 (6), p.1136-1141

2023

Volltextzugriff (PDF)

Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV

The New England journal of medicine, 2006-01, Vol.354 (3), p.251-260

2006

Volltextzugriff (PDF)

Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial

PloS one, 2019-01, Vol.14 (1), p.e0209911-e0209911

2019

Volltextzugriff (PDF)

Enteral nutrition management in critically ill adult patients and its relationship with intensive care unit-acquired muscle weakness: A national cohort study

PloS one, 2023-06, Vol.18 (6), p.e0286598-e0286598

2023

Volltextzugriff (PDF)

The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure

The Journal of infectious diseases, 2017-12, Vol.216 (suppl_9), p.S847-S850

2017

Volltextzugriff (PDF)

Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa

The New England journal of medicine, 2014-07, Vol.371 (3), p.234-247

2014

Volltextzugriff (PDF)

Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week results of a randomised, open-label, phase 3b, non-inferiority trial

The Lancet infectious diseases, 2014-07, Vol.14 (7), p.581-589

2014

Volltextzugriff (PDF)

Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study

Journal of acquired immune deficiency syndromes (1999), 2016-04, Vol.71 (5), p.530-537

2016

Volltextzugriff (PDF)

The Current Mismatch Between COVID-19 Clinical Trial Design and the Evolving Profile of Hospitalized Patients: A Retrospective Cohort Analysis

Clinical infectious diseases, 2024-04, Vol.78 (4), p.918-921

2024

Volltextzugriff (PDF)

Petrography and provenance of beach sands from volcanic oceanic islands: Cabo Verde, Atlantic Ocean

Journal of sedimentary research, 2021-01, Vol.91 (1), p.92-115

2021

Volltextzugriff (PDF)

Treatment of Ebola virus disease

Intensive care medicine, 2015-01, Vol.41 (1), p.115-117

2015

Volltextzugriff (PDF)

Week 48 efficacy and central nervous system analysis of darunavir/ritonavir monotherapy versus darunavir/ritonavir with two nucleoside analogues

AIDS (London), 2015-09, Vol.29 (14), p.1811-1820

2015

Volltextzugriff (PDF)

Efficacy of sotrovimab for persistent coronavirus disease-2019 in a severely immunocompromised person living with HIV

AIDS (London), 2022-04, Vol.36 (5), p.751-753

2022

Volltextzugriff (PDF)

96-Week results of abacavir/lamivudine versus tenofovir/emtricitabine, plus efavirenz, in antiretroviral-naive, HIV-1-infected adults: ASSERT study

Antiviral therapy, 2013-01, Vol.18 (7), p.905-913

2013

Volltextzugriff (PDF)

Comparison of Changes in Bone Density and Turnover with Abacavir-Lamivudine versus Tenofovir-Emtricitabine in HIV-Infected Adults: 48-Week Results from the ASSERT Study

Clinical infectious diseases, 2010-10, Vol.51 (8), p.963-972

2010

Volltextzugriff (PDF)

1 – 25 von 2.125

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.728)
Mit Volltextzugriff
(1.851)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.098)
Life Sciences & Biomedicine
(939)
Humans
(740)
Female
(453)
Male
(417)
Middle Aged
(298)
Adult
(296)
Infectious Diseases
(293)
Aged
(213)
Hiv Infections - Drug Therapy
(185)
Biological And Medical Sciences
(172)
Microbiology
(151)
Medical Sciences
(150)
Cardiovascular System & Cardiology
(140)
Immunology
(140)
Spain
(140)
Hiv
(139)
Cardiac & Cardiovascular Systems
(134)
Treatment Outcome
(121)
Human Immunodeficiency Virus
(120)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(19)
... seit 30 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Impact of COVID-19 on Madrid hospital system

Which trial do we need? Management of elderly, fragile, fully vaccinated patients hospitalized for SARS-CoV-2 infection

Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial

Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy : A Cohort Study

Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial

Clinical Management of Ebola Virus Disease in the United States and Europe

Probable sexual transmission of Zika virus from a vasectomised man

Broadly Neutralizing Antibodies for Human Immunodeficiency Virus Treatment: Broad in Theory, Narrow in Reality

Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV

Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial

Enteral nutrition management in critically ill adult patients and its relationship with intensive care unit-acquired muscle weakness: A national cohort study

The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure

Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa

Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study

The Current Mismatch Between COVID-19 Clinical Trial Design and the Evolving Profile of Hospitalized Patients: A Retrospective Cohort Analysis

Bone mineral density and inflammatory and bone biomarkers after darunavir–ritonavir combined with either raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial

Petrography and provenance of beach sands from volcanic oceanic islands: Cabo Verde, Atlantic Ocean

Treatment of Ebola virus disease

Week 48 efficacy and central nervous system analysis of darunavir/ritonavir monotherapy versus darunavir/ritonavir with two nucleoside analogues

Efficacy of sotrovimab for persistent coronavirus disease-2019 in a severely immunocompromised person living with HIV

96-Week results of abacavir/lamivudine versus tenofovir/emtricitabine, plus efavirenz, in antiretroviral-naive, HIV-1-infected adults: ASSERT study

Comparison of Changes in Bone Density and Turnover with Abacavir-Lamivudine versus Tenofovir-Emtricitabine in HIV-Infected Adults: 48-Week Results from the ASSERT Study

Suchergebnisse filtern